- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: FE203799 Placebo GLP-2 analogue
Total 3707 results
-
International AIDS Vaccine InitiativeBiomedical Advanced Research and Development AuthorityActive, not recruitingEbola Sudan Virus DiseaseUnited States
-
Algenis SpACompletedBack Pain | Acute PainChile
-
University Children Hospital HomburgCompleted
-
ValbiotisRecruiting
-
Aronora, Inc.CompletedThrombosis | End Stage Renal DiseaseUnited States
-
University of VermontInternational Centre for Diarrhoeal Disease Research, Bangladesh; Thrasher... and other collaboratorsCompletedRotavirus Infection | Vaccine Response Impaired | Vaccine Virus SheddingBangladesh
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...PfizerRecruitingCeliac Disease | Coeliac DiseaseUnited States, Canada, Poland, Germany
-
Janssen Research & Development, LLCCompletedHealthy | Asthma | Atopic DermatitisGermany, Belgium
-
Eric LenzeNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
Massachusetts General HospitalNational Institutes of Health (NIH)Unknown
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompletedSevere Acute Respiratory Syndrome Coronavirus 2Canada
-
National Institute of Allergy and Infectious Diseases...CompletedRespiratory Syncytial Virus InfectionsUnited States
-
Telavant, Inc.PfizerCompleted
-
Shenzhen Kexing Pharmaceutical Co., Ltd.Completed
-
Novozymes A/SUniversity of AarhusTerminated
-
University of California, DavisNational Institute on Aging (NIA); Forest LaboratoriesCompletedFragile X-Associated Tremor/Ataxia Syndrome | Fragile X Premutation CarriersUnited States
-
LEO PharmaCompletedActinic KeratosisCanada, United States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University HospitalRecruitingCentral Line-associated Bloodstream Infection (CLABSI)Denmark
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompletedDouble Vaccinated for COVID-19 (For Phase 1 of the Study) | Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)Canada
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompleted
-
Red de Terapia CelularCastilla-León Health Service; Instituto de Salud Carlos III; University of Valladolid and other collaboratorsCompletedCOVID-19 PneumoniaSpain
-
Maastricht UniversityNot yet recruitingType 2 Diabetes
-
Massachusetts General HospitalNational Institute on Aging (NIA)Unknown
-
Baiya Phytopharm Co., Ltd.Not yet recruitingCOVID-19 | COVID-19 VaccineThailand
-
Filip Krag KnopRecruitingObesity | Type 2 DiabetesDenmark
-
GenMont Biotech IncorporationNational Science Council, TaiwanCompleted
-
Cosmo Technologies LtdCompletedDiarrhea-predominant Irritable Bowel SyndromeBelgium, Germany, Italy, Spain
-
University Magna GraeciaCompletedCOVID-19 | SARS CoV 2 InfectionItaly
-
University of NottinghamUnknownSarcopenia | Muscle Atrophy | Muscle HypotrophyUnited Kingdom
-
University of California, DavisForest LaboratoriesWithdrawn
-
Novartis PharmaceuticalsRecruitingLupus NephritisFrance, Spain, Israel, Turkey, United States, Germany, India, Hungary, Malaysia, Portugal, Brazil, China, Puerto Rico, Hong Kong, Mexico, Singapore
-
Teikoku Pharma USA, Inc.Not yet recruiting
-
Zensun Sci. & Tech. Co., Ltd.Zensun USA Inc.CompletedChronic Heart FailureUnited States
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)Not yet recruitingTuberculosis, Pulmonary
-
Gustave Roussy, Cancer Campus, Grand ParisLinKinVaxRecruitingHead and Neck Carcinoma | Adult DiseaseFrance
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...Completed
-
Wei JiangNational Institute of Mental Health (NIMH)Completed
-
Guangzhou HuiBoRui Biological Pharmaceutical Technology...ParexelUnknownCorneal NeovascularizationUnited States
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Red de Terapia CelularUniversity of Valladolid; Hospital del Río Hortega; Hospital Clínico Universitario... and other collaboratorsRecruitingLupus Nephritis | Lupus ErythematosusSpain
-
GlaxoSmithKlineCompleted
-
Pharnext SACompletedPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)Charcot-Marie-Tooth Disease Type 1AUnited States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany
-
Bilix Co.,Ltd.RecruitingIschemia-reperfusion InjuryAustralia
-
Zydus Therapeutics Inc.Active, not recruitingPrimary Biliary CholangitisUnited States, Argentina, Iceland, Turkey
-
Universitätsklinikum Hamburg-EppendorfLudwig-Maximilians - University of Munich; University Hospital Tuebingen; Philipps... and other collaboratorsWithdrawn
-
Valo Health, Inc.Withdrawn
-
Theravance BiopharmaCompleted
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle BiostatisticsCompletedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, New Zealand, Canada, France, Puerto Rico